Semaglutide starts working within the first week — most people notice reduced appetite and earlier satiety within days. Measurable weight loss typically appears in weeks 1-4. Full effect requires reaching the maintenance dose (2.4 mg for Wegovy) which takes 16-20 weeks of titration. A1C reductions for diabetes start within 1-2 weeks but take 8-12 weeks at the maintenance dose to reach full effect because A1C is a slow-moving marker.
The Pharmacology Timeline
Semaglutide’s onset of action involves several overlapping phases:
Hours 1-72: Drug absorbs from the injection site and reaches peak blood levels in 1-3 days. GLP-1 receptors in the gut, pancreas, and brain start engaging immediately. Some people report reduced appetite or food preference changes within the first 24-48 hours.
Week 1: Appetite suppression noticeable in most people. Meal portions naturally shrink. Some report decreased “food noise” and lower interest in previously craved foods.
Weeks 1-5: Drug accumulates toward steady-state blood levels (about 5 weeks at any given dose). Each successive injection adds to the total exposure until steady-state is reached.
Weeks 4-16: Dose escalation phase. Each dose increase produces renewed appetite suppression and often a renewed wave of side effects. Weight loss accelerates as the dose climbs.
Week 17+: Maintenance dose (2.4 mg for Wegovy). Full effect, with steady-state blood levels reached by about week 22.
Weight Loss Timeline (STEP-1 Trial Data)
The STEP-1 trial enrolled 1,961 adults with obesity (without diabetes) on Wegovy 2.4 mg weekly. Average weight loss by timepoint:
| Week | Average % body weight lost | Average pounds lost (for 220-lb starting weight) |
|---|---|---|
| 4 | ~2% | ~4-5 lbs |
| 8 | ~4% | ~9 lbs |
| 12 | ~6% | ~13 lbs |
| 20 | ~10% | ~22 lbs |
| 28 | ~12% | ~26 lbs |
| 36 | ~13% | ~29 lbs |
| 52 | ~14% | ~31 lbs |
| 68 | ~15% | ~33 lbs |
These are averages — individual responses vary widely. Some people lose more rapidly; some lose more slowly; about 14 percent did not reach 5 percent weight loss.
A1C Timeline (For Diabetes Indication)
For type 2 diabetes treated with Ozempic, A1C reduction timeline:
- Weeks 1-4 (0.25 mg starting dose): fasting glucose drops; A1C unchanged
- Weeks 5-8 (0.5 mg): A1C starts dropping
- Weeks 9-12 (1 mg): Continued A1C reduction
- Weeks 12-16: Full A1C effect at the 1 mg dose, typically 1.5-2 percentage points lower than baseline
- Weeks 16+ (optional dose increase to 2 mg): Additional 0.4-0.5 percentage point reduction
The lag is partly because A1C reflects average blood sugar over the prior 2-3 months — the test physically cannot show a 2-week change as fully.
What “Working” Means at Each Phase
Days 1-7: Reduced appetite, smaller meals, earlier satiety. These are signs of GLP-1 engagement, not significant weight loss yet.
Weeks 2-4: 1-3 pounds of weight loss from reduced calorie intake. Glucose readings improving.
Weeks 4-12: 4-6 percent body weight loss at higher doses. A1C beginning to drop measurably.
Weeks 12-28: 10-12 percent body weight loss as dose reaches maintenance. Full A1C effect for diabetes.
Months 6-12: Approaching maximum weight loss potential. The rate of loss slows as your body adapts metabolically.
Year 1+: Maintenance and stabilization. Most people who continue semaglutide indefinitely maintain their loss; those who discontinue typically regain.
Factors That Speed Up or Slow Down Effect
Speeds up:
- Strict dietary discipline (eating only when hungry, avoiding sugary drinks)
- Regular physical activity, especially strength training
- Good sleep (7-9 hours nightly)
- Higher starting BMI (more weight to lose initially)
- Reaching maintenance dose without titration interruptions
Slows down:
- High-calorie liquid intake (sodas, juices, alcohol)
- Snacking despite no hunger
- Sedentary lifestyle
- Poor sleep or chronic stress
- Hypothyroidism or other untreated metabolic conditions
- Frequent titration interruptions for side effects
Setting Realistic Expectations
If you expect rapid dramatic weight loss in the first month, you’ll be disappointed. The first month’s loss is typically 1-3 pounds — modest. Significant loss requires reaching the higher doses, which takes months. Patience is essential.
If you’re using semaglutide for diabetes, A1C improvements will be visible at your 3-month follow-up labs. Don’t expect to see them at week 4.
The Bottom Line
Semaglutide starts reducing appetite within the first week, produces measurable weight loss within 4 weeks, and reaches full effect at the maintenance dose around week 17-22. A1C reductions for diabetes appear in 8-12 weeks. Individual responses vary widely; the 16-week titration is essential to minimize side effects. Be patient through the dose escalation period and reassess your progress at the maintenance dose. Consult your prescriber if you have concerns about your specific response. For more on GLP-1 treatment options, see our hub.
